Project Details
Project Description
| Status | Active |
|---|---|
| Effective start/end date | 15/02/24 → 14/02/29 |
A Phase 3 Multicenter, Long-Term Extension Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) in Subjects with Ulcerative Colitis
- Moore, Gregory (Primary Chief Investigator (PCI))
Project: Research